GOSS - Gossamer Bio, Inc.

QQQ $ 610.93 $ 0.00 (0 %)

DIA $ 469.41 $ 0.00 (0 %)

SPY $ 671.91 $ 0.00 (0 %)

TLT $ 92.13 $ 0.00 (0 %)

GLD $ 374.00 $ 0.00 (0 %)

Previous Close

$ 2.18

Open

$ 2.27

Bid

$ 2.21 x 50

Ask

$ 2.33 x 1,622

Day's Range

-- - --

52 Week Range

$ 0.66 - $ 3.60

Volume

4,084,419

Average Volume

Market Cap

495.69M

Beta (5Y Monthly)

$ 1.43

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	03-13-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-12-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	03-05-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-17-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	03-03-2022	12-31-2021	10-K
16	11-08-2021	09-30-2021	10-Q
17	08-09-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	02-26-2021	12-31-2020	10-K
20	11-10-2020	09-30-2020	10-Q
21	08-11-2020	06-30-2020	10-Q
22	05-12-2020	03-31-2020	10-Q
23	03-24-2020	12-31-2019	10-K
24	11-12-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-14-2019	03-31-2019	10-Q
27	03-22-2019	12-31-2018	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Gossamer Bio Enters into Option Agreement ...
09/25/2025 11:32:33

Gossamer Bio To Present At European Respir...
09/22/2025 11:37:18

Cantor Fitzgerald Reiterates Overweight on...
09/11/2025 12:32:05

Cantor Fitzgerald analyst Olivia Brayer reiterates Gossamer Bio (NASDAQ:GOSS) from Overweight to Overweight.

this-saia-analyst-turns-bullish-here-are-top-4-upgrades-for-wednesday

This Saia Analyst Turns Bullish; Here Are ...
09/10/2025 11:50:01

UBS Upgrades Gossamer Bio to Buy, Raises P...
09/10/2025 10:44:11

UBS analyst Eliana Merle upgrades Gossamer Bio (NASDAQ:GOSS) from Neutral to Buy and raises the price target from $1.25 to $9.

Wedbush Maintains Outperform on Gossamer B...
08/06/2025 15:59:14

Wedbush analyst Laura Chico maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $4 to $5.

Gossamer Bio Q2 EPS $(0.17) Beats $(0.18) ...
08/05/2025 20:24:43

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) ...

ultragenyx-pharmaceutical-apple-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

Ultragenyx Pharmaceutical, Apple And Other...
07/14/2025 12:14:56

Scotiabank Initiates Coverage On Gossamer ...
07/14/2025 11:53:08

Scotiabank analyst Greg Harrison initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Sector Outperform rating and announ...

Gossamer Bio Completes Enrollment In Phase...
06/16/2025 11:36:20

Gossamer Bio Completes Enrollment In Regis...
06/16/2025 11:33:53

Goldman Sachs Maintains Buy on Gossamer Bi...
05/16/2025 16:49:55

Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and raises the price target from $7 to $8.

Wedbush Reiterates Outperform on Gossamer ...
05/16/2025 14:02:57

Wedbush analyst Laura Chico reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and maintains $4 price target.

Gossamer Bio Q1 EPS $(0.16) Beats $(0.18) ...
05/15/2025 20:03:05

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) ...

Earnings Scheduled For May 15, 2025
05/15/2025 08:32:23

Exploring Gossamer Bio's Earnings Expectat...
05/14/2025 20:07:43

Gossamer Bio To Present Preclinical Data A...
05/07/2025 20:07:00

Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization o...

Goldman Sachs Maintains Buy on Gossamer Bi...
04/17/2025 17:38:17

Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $8 to $7.

HC Wainwright & Co. Reiterates Buy on Goss...
03/18/2025 10:37:40

HC Wainwright & Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $10 price ta...

Wedbush Reiterates Outperform on Gossamer ...
03/14/2025 13:45:03

Wedbush analyst Laura Chico reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and maintains $4 price target.